NCT01075516

Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Defibrillator (ICD) Patients

TARIFF Health Economics Evaluation Registry for Remote Follow up

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 209 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to define the economic value of implantable cardioverter defibrillator (ICD) remote monitoring for hospitals, third payers and patients in Italy. Aims of the study are to develop a hospital cost minimization analysis and a cost effectiveness analysis based on direct estimation of costs and quality of life deriving from remote follow-up (performed with Merlin@home and Merlin.net) compared to standard follow-up in the management of ICD implanted patients.

Detailed description

TARIFF is a prospective observational study aimed to measure direct, indirect costs and quality of life of all participants for the duration of the observational timeframe. Purpose of cost collecting is to include a complete set of medical services and productivity loses that could be directly affected by the different clinical Follow-Up (FU) pathway. The study consists of 2 phases: firstly standard follow up costs will be collected for 100 pts, then all costs associated to remote follow ups will be collected for other 100 patients.

Conditions

• Complication of Cardiac Defibrillator

Timeline

• Start date: 2009-12-01
• Primary completion: 2012-03-01
• Completion: 2013-04-01
• First posted: 2010-02-25
• Last updated: 2021-03-03
• Results posted: 2021-03-03

Locations

6 sites across 1 country: Italy